N-Myc (MYCN) belongs to the MYC family and was originally identified as being amplified in 20–30% of neuroblastoma tumours, but it is now well established that dysregulation of this transcription factor is common in many non-neuronal tumours [120]. Here, MYCN is linked to neoplasm.